Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations Justin A. ChenJonathan W. Riess Lung Cancer (HA Wakelee and TA Leal, Section Editors) 25 June 2020 Article: 60
Clinical Development of PD-1/PD-L1 Inhibitors in Breast Cancer: Still a Long Way to Go Romualdo Barroso-SousaSara M. Tolaney Breast Cancer (WJ Gradishar, Section Editor) 17 June 2020 Article: 59
Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives? Tina W. ZhangDavid PalmaLucas C. Mendez Gynecologic Cancers (LA Cantrell, Section Editor) 12 June 2020 Article: 58
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults Anand A. PatelJoseph ThomasWendy Stock Leukemia (PH Wiernik, Section Editor) 28 May 2020 Article: 57
Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma Gaya SpolveratoDario CallegaroAlessandro Gronchi Sarcoma (SH Okuno, Section Editor) 27 May 2020 Article: 56
Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates Sheima FaragMyles J. SmithRobin L. Jones Sarcoma (SH Okuno, Section Editor) Open access 27 May 2020 Article: 55
Management of the Axilla after Neoadjuvant Systemic Therapy Trista J. Stankowski-DrenglerHeather B. Neuman Breast Cancer (WJ Gradishar, Section Editor) 27 May 2020 Article: 54
Exercise Training for Cancer Survivors Calvin K.W. TongBenny LauMargot K. Davis Cardio-oncology (MG Fradley, Section Editor) 27 May 2020 Article: 53
